These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 7940959

  • 1. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959
    [No Abstract] [Full Text] [Related]

  • 2. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115
    [No Abstract] [Full Text] [Related]

  • 3. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F, Chong A, Foster P, Sankary H, McChesney L, Williams JM, Frieders D, Williams JW.
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract] [Full Text] [Related]

  • 4. Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
    Foster PF, Kociss K, Shen J, Sankary HN, Xiao F, Williams JW.
    Transplant Proc; 1996 Oct; 28(5):2527-8. PubMed ID: 8907935
    [No Abstract] [Full Text] [Related]

  • 5. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F, Shen J, Chong A, Liu W, Foster P, Blinder HL, Sankary H, McChesney L, Mital D, Williams JW.
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract] [Full Text] [Related]

  • 6. Effect of leflunomide and cyclosporine on the occurrence of chronic xenograft lesions.
    Lin Y, Vandeputte M, Waer M.
    Kidney Int Suppl; 1995 Dec; 52():S23-8. PubMed ID: 8587278
    [Abstract] [Full Text] [Related]

  • 7. Leflunomide controls rejection in hamster to rat cardiac xenografts.
    Xiao F, Chong AS, Foster P, Sankary H, McChesney L, Koukoulis G, Yang J, Frieders D, Williams JW.
    Transplantation; 1994 Oct 15; 58(7):828-34. PubMed ID: 7940718
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1995 Feb 15; 27(1):305-6. PubMed ID: 7879012
    [No Abstract] [Full Text] [Related]

  • 9. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS, Shen J, Xiao F, Blinder L, Foster P, Sankary H, Williams JW.
    Transplant Proc; 1996 Apr 15; 28(2):684. PubMed ID: 8623344
    [No Abstract] [Full Text] [Related]

  • 10. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA, Cramer DV, Tuso PJ, Chapman FA, Wang HK, Makowka L.
    J Heart Lung Transplant; 1994 Apr 15; 13(3):489-97. PubMed ID: 8061026
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms involved in long-term hamster-to-rat cardiac xenograft survival.
    Lin Y, Vandeputte M, Waer M.
    Transplant Proc; 1996 Apr 15; 28(2):683. PubMed ID: 8623343
    [No Abstract] [Full Text] [Related]

  • 12. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD, Gandy KL, Morris RE, Hoyt G, Gutierrez J, Reitz BA, Robbins RC.
    J Heart Lung Transplant; 1995 Apr 15; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [Abstract] [Full Text] [Related]

  • 13. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y, Waer M.
    Transplant Proc; 1996 Dec 15; 28(6):3159. PubMed ID: 8962224
    [No Abstract] [Full Text] [Related]

  • 14. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW, Xiao F, Foster P, Clardy C, McChesney L, Sankary H, Chong AS.
    Transplantation; 1994 Apr 27; 57(8):1223-31. PubMed ID: 8178350
    [Abstract] [Full Text] [Related]

  • 15. Effects of cholera toxin in xenograft survival.
    Sakakibara N, Tsuru S, Shinomiya N, Click RE, Hirata K, Jamieson SW.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):423-4. PubMed ID: 8438363
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival.
    Lucien J, Marath A, Rayat G, Thliveris J, Koshal A, Yatscoff R.
    Transplant Proc; 1996 Apr 27; 28(2):704-7. PubMed ID: 8623356
    [No Abstract] [Full Text] [Related]

  • 17. Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.
    Cosenza CA, Tuso PJ, Chapman FA, Middleton YD, Cramer DV, Wu GD, Makowka L.
    Transplant Proc; 1993 Jun 27; 25(3 Suppl 2):59-60. PubMed ID: 8516946
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D, Achilleos O, Lee SJ, Dalgic A, Mayer AD, Buckels JA, McMaster P, D'Silva M.
    Transplant Proc; 1994 Dec 27; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract] [Full Text] [Related]

  • 19. Effect of leflunomide, cyclosporine, and splenectomy in two different organ systems of concordant xenotransplantation in rats.
    Salomon S, Steinbrüchel DA, Nielsen B, Lillevang S, Kemp E.
    Transplant Proc; 1996 Apr 27; 28(2):698-9. PubMed ID: 8623352
    [No Abstract] [Full Text] [Related]

  • 20. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
    Takeshita K, Arakawa K, Okamoto M, Akioka K, Fujiwara I, Kobayashi K, Imanishi J, Oka T.
    Transplant Proc; 1996 Apr 27; 28(2):631-2. PubMed ID: 8623314
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.